History of the Frazer Institute

A new chapter

In 2026, the Frazer Institute entered a new phase of its history, expanding to bring together complementary strengths in biomedical discovery, clinical research and applied health sciences to form one of Australia’s most comprehensive clinical–translational research institutes.

This expansion builds on the Institute’s long‑standing foundations while incorporating research capability previously based within the UQ Centre for Clinical Research, together with nationally significant programs from the Centre for Health Services Research. These additions broaden the Institute’s capacity to deliver on translational outcomes at all levels, constituting the first end-to-end translational institute.

Today, the Frazer Institute operates across the Herston and Dutton Park campuses and works closely with major health partners including the Royal Brisbane and Women’s Hospital, Princess Alexandra Hospital and the Translational Research Institute. It is well integrated within the Herston health precinct and the Boggo Road innovation Junction in what is called Brisbane’s corridor of knowledge. While the Institute continues to evolve, it remains firmly grounded in the principles that have shaped its history: scientific excellence, collaboration and partnerships, and research that improves health outcomes.

Foundations and early discovery

The Frazer Institute has its origins in discovery‑driven biomedical research at The University of Queensland, with a particular focus on virology, immunology and translational medicine. From its earliest years, the Institute has been distinguished by close connections between laboratory science and clinical application.

The Institute is named in honour of Emeritus Professor Ian Frazer AC, whose pioneering work in immunology and virology delivered the HPV vaccine that has globally saved millions of women from cervical cancer. This exemplifies the Institute’s mission to translate scientific discovery into real‑world health benefit. This legacy of discovery and translation has shaped the Institute’s research culture and international reputation.

Growth through collaboration and translation

Over time, the Frazer Institute expanded its research portfolio through interdisciplinary collaboration and strong partnerships with hospitals, clinicians, industry and community stakeholders. Its work has encompassed fundamental biomedical research as well as clinical and population‑level studies, reflecting a commitment to addressing complex health challenges from multiple perspectives.

The Institute’s location within major health precincts has enabled sustained engagement with clinicians and health services, supporting research that informs prevention, diagnosis, treatment and implementation in real‑world settings. This emphasis on translation and partnership has remained a defining feature of the Institute’s identity.

An evolving institute

The expansion of the Frazer Institute in 2026 represents a continuation of this trajectory—building on a strong legacy while strengthening scale, connectivity and impact. By bringing together complementary research capabilities across discovery, clinical trials, implementation science and health systems research, the Institute is positioned to address current and emerging health priorities with greater integration and reach.

As the Frazer Institute moves forward, it continues to honour its history while embracing new opportunities for collaboration and leadership in translational health research.